Harrow Health (HROW) Misses Q3 EPS by 7c

Harrow Health (NASDAQ: HROW) reported Q3 EPS of ($0.12), $0.07 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $34.3 million versus the consensus estimate of $52.8 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
• Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
• Investec Double Upgrades Alkem Laboratories Ltd (ALKEM:IN) to Buy